NewGenIvf (NIVF): צמיחה צפויה ברווח למניה לשנה הבאה

The development of NewGenIvf Group Limited relies on government support for birth rates in China and Thailand, as well as medical tourism. This chart from the GURU.Markets platform illustrates the expected growth of earnings per share for next year, where the value of 0.00 characterizes this level. The business is moderately cyclical, as IVF is often self-funded, and high competition limits the company's pricing power.

This indicator aggregates analyst consensus forecasts for net profit growth rates for the coming year, reflecting market expectations regarding income generation efficiency. The current value of 0.00, combined with changes in earnings per share price targets, confirms the high resilience of NewGenIvf Group Limited (NIVF), whose impeccable reputation in Asia's reproductive medicine sector ensures a steady patient inflow and long-term financial reliability.